News | News By Subject | News by Disease News By Date | Search News

Endometrial Cancer News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News

News from Around the Web
Black Women With Fibroids Face Elevated Risk Of Endometrial Cancer, Boston University Study     3/30/2016
Drinking Coffee May Lower Endometrial Cancer Risk, Imperial College London Study     2/9/2015
No Proof That Soy Food Protects Against Cancer, National Cancer Center Study     6/20/2014
Diabetes Treatment May Also Provide Protection Against Endometrial Cancer, University of Warwick and Warwick Medical School Study     4/6/2011
'Sandwich' Tx Helps in Rare Endometrial Cancer, Montefiore Medical Center Study     3/9/2011
How Dietary Supplement May Block Cancer Cells, Ohio State University Study     7/1/2010
New Chemotherapy Combination Shows Promise in Endometrial Cancer, University of Texas MD Anderson Cancer Center Researchers Find     3/19/2010
Single Gene Mutation Induces Endometrial Cancer, UT Southwestern Medical Center Study     2/12/2010
Potent Suppressor Of Endometrial Cancer Is Revealed, University of Texas Southwestern Medical Center and Harvard Medical School Study     2/8/2010
Gene Mutation Marks Aggressive Endometrial Cancer, Washington University School of Medicine Study     5/28/2009
Contraceptives Protect Against Endometrial Cancer     11/22/2006
Two Types Of HRT Raise Risk Of Womb Cancer     4/29/2005
Study Confirms Tamoxifen Raises Endometrial Cancer Risk     3/2/2005
Tamoxifen's Side Effects Scare Away Some     12/15/2004
Animal Research Suggests That Stress May Increase Risk Of Uterine Cancer     7/12/2004

Press Releases
Further Study Of Combination Of Eisai Inc. (ESALF.PK)'s Lenvatinib And Merck & Co. (MRK)'s Pembrolizumab In Previously Treated Patients With Metastatic Endometrial Cancer Supported By Interim Analysis Of Ongoing Phase Ib/II Trial     6/5/2017
AEterna Zentaris (AEZS) Falling Hard On Failed Late-Stage Cancer Trial     5/1/2017
Tesaro (TSRO) Initiates Registrational Development Program For Anti-PD-1 Antibody TSR-042     4/27/2017
Xenetic Biosciences Announces FDA Acceptance Of Investigational New Drug Application To Initiate Phase II Clinical Trial Of Virexxa In Endometrial Cancer     8/19/2016
ASCO2016: AEterna Zentaris (AEZS) Reconfirms Commitment To LHRH-Receptor Targeting Zoptrex During 2016 ASCO Annual Meeting     6/7/2016
Myriad Genetics (MYGN) Release: The Myriad Myrisk Hereditary Cancer Test Identifies 60 Percent More Deleterious Mutations In Patients With Endometrial Cancer     3/18/2016
PapGene, Inc. Awarded Grant For Test To Detect Ovarian And Endometrial Cancers     2/4/2016
AEterna Zentaris (AEZS) To Participate In 18th Annual BIO CEO & Investor Conference Seeking Partnering Opportunities     2/2/2016
ArQule, Inc. (ARQL) To Present Data On Tivantinib, ARQ 087, ARQ 092, And ARQ 751 At AACR-NCI-EORTC Conference     10/27/2015
AEterna Zentaris (AEZS): Data And Safety Monitoring Board Recommends Continuation Of ZoptEC Phase 3 Trial In Advanced Endometrial Cancer     10/13/2015
Galena Biopharma  (GALE) Presents Positive GALE-301 Phase 2a Clinical Trial Data At The European Cancer Congress 2015     9/28/2015
Galena Biopharma  (GALE) To Present GALE-301 Phase 2a Clinical Trial Data At The European Society For Medical Oncology (ESMO)     9/14/2015
Esperance Pharmaceuticals, Inc. Announces Strategic Alliance With MD Anderson Cancer Center     8/24/2015
AEterna Zentaris (AEZS) Second Quarter Financial And Operating Results     8/14/2015
AEterna Zentaris (AEZS) Announces Data And Safety Monitoring Board Scheduled To Complete Second Interim Analysis Of The ZoptEC Phase 3 Trial In Endometrial Cancer In Early October     8/11/2015